Renal Cancer - Results from #860

A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. June 29, 2023

Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors from Renal Cell Carcinoma in Routine Clinical Practice. June 29, 2023

Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy. June 28, 2023

Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. June 28, 2023

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. June 28, 2023

FN1 and cancer-associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma. June 27, 2023

Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT). June 27, 2023

Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome: Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas". June 27, 2023

Analysis of clinical characteristics and prognostic factors of elderly patients with renal cell carcinoma based on the SEER database. June 26, 2023

Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy. June 26, 2023

Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma. June 23, 2023

Role of AI and Radiomic Markers in Early Diagnosis of Renal Cancer and Clinical Outcome Prediction: A Brief Review. June 23, 2023

Metabolic reprogramming of clear cell renal cell carcinoma. June 23, 2023

Advanced fumarate hydratase-deficient renal cell carcinoma responding to combination immune checkpoint inhibitors. June 23, 2023

Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. June 22, 2023

Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma. June 22, 2023

First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer. June 21, 2023

The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients with Surgically Resected Metastatic Renal Cell Carcinoma. June 21, 2023

Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study. June 20, 2023

Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear-cell renal cell carcinoma. June 20, 2023

Page 44 of 456